A61K 39/215
Coronaviridae
Official title: Coronaviridae, e.g. avian infectious bronchitis virus
A61K39/215 (Coronaviridae) appears on 513 US grants and 1,511 published applications in this corpus.
Search patents in A61K- Granted patents
- 513
- Published applications
- 1,511
- Assignees
- 793
- Inventors
- 3,935
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 4 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 1 | 4 |
| 2003 | 2 | 5 |
| 2004 | 0 | 6 |
| 2005 | 1 | 11 |
| 2006 | 2 | 15 |
| 2007 | 4 | 12 |
| 2008 | 11 | 11 |
| 2009 | 3 | 7 |
| 2010 | 7 | 10 |
| 2011 | 2 | 5 |
| 2012 | 1 | 2 |
| 2013 | 4 | 2 |
| 2014 | 3 | 12 |
| 2015 | 3 | 8 |
| 2016 | 9 | 15 |
| 2017 | 10 | 20 |
| 2018 | 17 | 19 |
| 2019 | 12 | 23 |
| 2020 | 17 | 35 |
| 2021 | 42 | 107 |
| 2022 | 55 | 154 |
| 2023 | 53 | 302 |
| 2024 | 72 | 330 |
| 2025 | 76 | 252 |
| 2026 | 64 | 143 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Polypeptides, compositions, and their use to treat or limit development of an infection6 Oct 2026US 12,752,002 B2University of Washington
- Lipidated FLIPr and uses thereof in vaccine6 Oct 2026US 12,752,003 B2National Health Research Institutes
- Recombinant modified vaccinia virus (MVA) vaccine against coronavirus disease29 Sep 2026US 12,746,282 B2Bavarian Nordic A/S
- High-potency SARS coronavirus 2 antigen and vaccine composition comprising same29 Sep 2026US 12,747,268 B2Korea Research Institute of Chemical Technology
- Variant strain-based coronavirus vaccines22 Sep 2026US 12,741,019 B2ModernaTX, Inc.
- Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof8 Oct 2026US 2026/0306419 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Vaccine compositions8 Oct 2026US 2026/0306614 A1Sail Biomedicines
- Combination Vaccine8 Oct 2026US 2026/0306615 A1Seqirus Inc.
- Spike Protein Based Genetic Vaccines8 Oct 2026US 2026/0306616 A1University of Maryland, Baltimore
Most cited
By later US patents
- Combination PIV3/hMPV RNA vaccines110US 10,064,934 B2ModernaTX, Inc. · 2018
- Coronavirus vaccine51US 11,241,493 B2CureVac AG · 2022
- Betacoronavirus mRNA vaccine46US 10,702,600 B1ModernaTX, Inc. · 2020
- Coronavirus vaccine formulations46US 10,953,089 B1Novavax, Inc. · 2021
- Stabilized coronavirus spike (S) protein immunogens and related vaccines40US 10,906,944 B2The Scripps Research Institute · 2021